Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

upgd:-avoid-this-poorly-designed-analyst-ratings-improvers-etf

UPGD: Avoid This Poorly Designed Analyst Ratings Improvers ETF

Mar 11, 2026

UPGD ETF gets a sell rating: flawed analyst-rating screen limits holdings to neutral-to-buy stocks, hurting returns vs. SPY/RSP.…

Read more
this-ligand-pharmaceuticals-analyst-begins-coverage-on-a-bullish-note;-here-are-top-4-initiations-for-wed

This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wed

Mar 11, 2026

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…

Read more
2-stocks-in-focus-from-new-analyst-coverage-amid-uncertainty

2 Stocks in Focus From New Analyst Coverage Amid Uncertainty

Mar 11, 2026

Key Takeaways CBAN gains attention after new analyst coverage; shares rose 13.2% in six months despite industry decline.…

Read more
ubs-maintained-buy-on-western-alliance-bancorporation-(wal)-march-10,-2026

UBS Maintained Buy on Western Alliance Bancorporation (WAL) March 10, 2026

Mar 11, 2026

UBS maintained a Buy on Western Alliance Bancorporation (WAL) on March 10, 2026, marking the latest WAL analyst…

Read more
ubs-maintains-neutral-on-stem,-inc.-(stem)-mar-10,-2026

UBS Maintains Neutral on Stem, Inc. (STEM) Mar 10, 2026

Mar 11, 2026

UBS maintained a Neutral rating on Stem, Inc. (STEM) on March 10, 2026, while lowering its price target…

Read more
ubs-maintains-sell-on-national-beverage-corp.-(fizz),-pt-cut-to-$34-mar-2026

UBS Maintains Sell on National Beverage Corp. (FIZZ), PT Cut to $34 Mar 2026

Mar 11, 2026

UBS maintained a Sell on National Beverage Corp. (FIZZ) on March 10, 2026, and cut its price target…

Read more
cantor-fitzgerald-keeps-overweight-on-beta-(beta-technologies,-inc.)-mar-2026

Cantor Fitzgerald Keeps Overweight on BETA (BETA Technologies, Inc.) Mar 2026

Mar 11, 2026

Cantor Fitzgerald on March 10, 2026 maintained an Overweight rating on BETA Technologies, Inc. and lowered the price…

Read more
amprius-technologies-(ampx)-reports-earnings-&-sees-analyst-coverage

Amprius Technologies (AMPX) Reports Earnings & Sees Analyst Coverage

Mar 11, 2026

We recently published 9 Best Battery Stocks to Buy Before They Explode. Amprius Technologies Inc. (NYSE:AMPX) is one…

Read more
cantor-fitzgerald-keeps-overweight-on-nbix-neurocrine-biosciences-march-2026

Cantor Fitzgerald Keeps Overweight on NBIX Neurocrine Biosciences March 2026

Mar 11, 2026

On March 10, 2026 Cantor Fitzgerald kept NBIX at Overweight and raised its price target to $195. The…

Read more
leerink-maintains-outperform-on-3d-systems-corporation-(ddd)-march-10,-2026

Leerink Maintains Outperform on 3D Systems Corporation (DDD) March 10, 2026

Mar 11, 2026

Leerink Partners maintained an Outperform on 3D Systems Corporation on March 10, 2026, marking the primary DDD analyst…

Read more
cowen-maintains-buy-on-chewy,-inc.-(chwy)-march-10,-2026

Cowen Maintains Buy on Chewy, Inc. (CHWY) March 10, 2026

Mar 11, 2026

Cowen & Co. maintained its Buy on Chewy, Inc. (CHWY) on March 10, 2026 and lowered the price…

Read more
william-blair-maintains-outperform-on-lenz-therapeutics,-inc-(lenz)-march-10-2026

William Blair Maintains Outperform on LENZ Therapeutics, Inc (LENZ) March 10 2026

Mar 11, 2026

William Blair maintained an Outperform rating on LENZ Therapeutics, Inc. (LENZ) on March 10, 2026. The call reiterates…

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 9
  6. 10
  7. 11
  8. 12
  9. 13
  10. 14
  11. 15
  12. ...
  13. 377
  14. »

Posts pagination

Newer posts Page 1 … Page 12 … Page 377 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.